Microfluidic outer blood-retinal barrier model for inducing wet age-related macular degeneration by hypoxic stress.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36254466.
- Also identified by DOI 10.1039/d2lc00672c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wet age-related macular degeneration (AMD) is a severe ophthalmic disease that develops in the outer blood-retinal barrier (oBRB), involving two types of cells, the retinal pigment epithelium (RPE) and the choriocapillaris endothelium (CCE). Unfortunately, the pathogenesis of AMD is unclear, and the risk of the only effective therapy (Anti-VEGF injection) has been consistently argued. Also, since oBRB is hard to observe <i>in vivo</i>, an <i>in vitro</i> model for the pathological study is necessary. Here, we propose an advanced oBRB model, enhanced in two major ways: fully vascularized CCE and the <i>in vivo</i> analogous distance between RPE and CCE. Our model consists of an RPE (ARPE-19) monolayer with adjacent CCE (HUVEC) embedded fibrin gel in the microfluidic chip and required four days to construct an oBRB. Notably, the intercellular distance was tuned to the <i>in vivo</i> scale (<100 μm) without any extraneous scaffold in between. Thus, the two cell layers can interact freely through the extracellular matrix (ECM) <i>in vivo</i>. This is significant as wet AMD is mainly developed through broken intercellular interaction. Thanks to this <i>in vivo</i> similarity, the model incubated under hypoxic conditions, similar to an oxygen-induced retinopathy animal model, showed upregulated vascularization comparable to the AMD condition. We envisage that our model can be used to assist the investigation of AMD.
Medical subject headings
- Macular Degeneration
- Wet Macular Degeneration